HK1170503A1 - Beta cell marker antibody - Google Patents

Beta cell marker antibody

Info

Publication number
HK1170503A1
HK1170503A1 HK12111220.5A HK12111220A HK1170503A1 HK 1170503 A1 HK1170503 A1 HK 1170503A1 HK 12111220 A HK12111220 A HK 12111220A HK 1170503 A1 HK1170503 A1 HK 1170503A1
Authority
HK
Hong Kong
Prior art keywords
cell marker
beta cell
marker antibody
antibody
beta
Prior art date
Application number
HK12111220.5A
Other languages
English (en)
Chinese (zh)
Inventor
謝斯廷‧揚-霍夫曼
桑納何‧索夫曼‧詹森
胡格斯‧馬蒂勒
克里斯蒂亞諾‧米廖裡尼
王海燕
Original Assignee
霍夫曼-拉羅奇有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 霍夫曼-拉羅奇有限公司 filed Critical 霍夫曼-拉羅奇有限公司
Publication of HK1170503A1 publication Critical patent/HK1170503A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK12111220.5A 2009-08-04 2012-11-07 Beta cell marker antibody HK1170503A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09167160 2009-08-04
PCT/EP2010/061078 WO2011015521A1 (en) 2009-08-04 2010-07-30 Beta cell marker antibody

Publications (1)

Publication Number Publication Date
HK1170503A1 true HK1170503A1 (en) 2013-03-01

Family

ID=42938156

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111220.5A HK1170503A1 (en) 2009-08-04 2012-11-07 Beta cell marker antibody

Country Status (13)

Country Link
US (1) US8512704B2 (xx)
EP (1) EP2462163A1 (xx)
JP (1) JP5684259B2 (xx)
KR (1) KR20120051733A (xx)
CN (1) CN102471383B (xx)
AU (1) AU2010280847B2 (xx)
BR (1) BR112012002460A2 (xx)
CA (1) CA2768745C (xx)
HK (1) HK1170503A1 (xx)
IL (1) IL217371A0 (xx)
MX (1) MX2012001018A (xx)
SG (1) SG178210A1 (xx)
WO (1) WO2011015521A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012113718A1 (en) * 2011-02-21 2012-08-30 Roche Diagnostics Gmbh A diagnostic method for type ii diabetes
US10032064B2 (en) 2012-08-21 2018-07-24 Cambridge Research & Instrumentation, Inc. Visualization and measurement of cell compartments
WO2017182605A1 (en) * 2016-04-22 2017-10-26 Université Libre de Bruxelles A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
JP2019532027A (ja) 2016-08-17 2019-11-07 ソルスティス バイオロジクス，リミティッド ポリヌクレオチド構築物
US11597744B2 (en) 2017-06-30 2023-03-07 Sirius Therapeutics, Inc. Chiral phosphoramidite auxiliaries and methods of their use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5204244A (en) 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
US5397703A (en) * 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
SG146644A1 (en) * 2003-09-18 2008-10-30 Raven Biotechnologies Inc Kid3 and kid3 antibodies that bind thereto
WO2006133333A2 (en) * 2005-06-07 2006-12-14 The Rockefeller University Stimulation of pancreatic b cell proliferation
EA016186B1 (ru) * 2005-09-26 2012-03-30 Медарекс, Инк. Человеческие моноклональные антитела к cd70 и их применение

Also Published As

Publication number Publication date
JP5684259B2 (ja) 2015-03-11
CN102471383A (zh) 2012-05-23
CA2768745C (en) 2015-02-03
SG178210A1 (en) 2012-03-29
US8512704B2 (en) 2013-08-20
MX2012001018A (es) 2012-02-21
KR20120051733A (ko) 2012-05-22
BR112012002460A2 (pt) 2016-11-08
CA2768745A1 (en) 2011-02-10
EP2462163A1 (en) 2012-06-13
US20120134927A1 (en) 2012-05-31
AU2010280847B2 (en) 2012-12-13
IL217371A0 (en) 2012-02-29
WO2011015521A1 (en) 2011-02-10
JP2013501023A (ja) 2013-01-10
CN102471383B (zh) 2014-09-17
AU2010280847A1 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
HUS1900048I1 (hu) Anti-IL-23 antitestek
HK1249547A1 (zh) 鹽藻糖基化欠缺細胞
IL214996A0 (en) Anti-bcma antibodies
GB0920127D0 (en) Antibodies
ZA201104545B (en) Anti-siglec-15 antibody
GB0909906D0 (en) Antibodies
GB0908613D0 (en) T Cell Reseptors
EP2427496A4 (en) ANTI-VEGF-D ANTIBODIES
GB0920324D0 (en) Antibodies
PL2317294T3 (pl) Komórka pomiarowa
HK1170503A1 (en) Beta cell marker antibody
GB0920775D0 (en) Cells
GB2473934B (en) Anti-VEEV antibody
EP2499256A4 (en) ANTI-C-MPL ANTIBODIES
EP2424892A4 (en) DC-STAMP ANTIBODY
GB0911712D0 (en) Antibody
GB0908945D0 (en) Antibodies
HU0900248D0 (en) Serum for soil
HU0900386D0 (en) Serum for soil
GB0920035D0 (en) Cell
GB0915268D0 (en) Cell culture
GB0922428D0 (en) Cell culture
HUE052153T2 (hu) Fukoziláció-deficiens sejtek
GB0908223D0 (en) Cells
GB0901675D0 (en) Cells

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180730